BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29892709)

  • 1. Neurodegeneration as the presenting symptom in 2 adults with xeroderma pigmentosum complementation group F.
    Shanbhag NM; Geschwind MD; DiGiovanna JJ; Groden C; Godfrey R; Yousefzadeh MJ; Wade EA; Niedernhofer LJ; Malicdan MCV; Kraemer KH; Gahl WA; Toro C
    Neurol Genet; 2018 Jun; 4(3):e240. PubMed ID: 29892709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult-Onset Neurodegeneration in Nucleotide Excision Repair Disorders (NERD
    Cordts I; Önder D; Traschütz A; Kobeleva X; Karin I; Minnerop M; Koertvelyessy P; Biskup S; Forchhammer S; Binder J; Tzschach A; Meiss F; Schmidt A; Kreiß M; Cremer K; Mensah MA; Park J; Rautenberg M; Deininger N; Sturm M; Lingor P; Klopstock T; Weiler M; Marxreiter F; Synofzik M; Posch C; Sirokay J; Klockgether T; Haack TB; Deschauer M
    Mov Disord; 2022 Aug; 37(8):1707-1718. PubMed ID: 35699229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep intronic founder mutations identified in the
    Senju C; Nakazawa Y; Oso T; Shimada M; Kato K; Matsuse M; Tsujimoto M; Masaki T; Miyazaki Y; Fukushima S; Tateishi S; Utani A; Murota H; Tanaka K; Mitsutake N; Moriwaki S; Nishigori C; Ogi T
    Proc Natl Acad Sci U S A; 2023 Jul; 120(27):e2217423120. PubMed ID: 37364129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xeroderma pigmentosum complementation group F: A rare cause of cerebellar ataxia with chorea.
    Carré G; Marelli C; Anheim M; Geny C; Renaud M; Rezvani HR; Koenig M; Guissart C; Tranchant C
    J Neurol Sci; 2017 May; 376():198-201. PubMed ID: 28431612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Identification of a Heterozygous XPA c.553C>T Mutation Causing Neurological Impairment in a Case of Xeroderma Pigmentosum Complementation Group A.
    García-Carmona JA; Yousefzadeh MJ; Alarcón-Soldevilla F; Fages-Caravaca E; Kieu TL; Witt MA; López-Ávila Á; Niedernhofer LJ; Pérez-Vicente JA
    Front Genet; 2021; 12():717361. PubMed ID: 34484303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cockayne syndrome and xeroderma pigmentosum.
    Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
    Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D).
    Lai JP; Liu YC; Alimchandani M; Liu Q; Aung PP; Matsuda K; Lee CC; Tsokos M; Hewitt S; Rushing EJ; Tamura D; Levens DL; Digiovanna JJ; Fine HA; Patronas N; Khan SG; Kleiner DE; Oberholtzer JC; Quezado MM; Kraemer KH
    Acta Neuropathol Commun; 2013 May; 1():4. PubMed ID: 24252196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: Variants in the
    Kulikowska J; Jakubiuk-Tomaszuk A; Rydzanicz M; Płoski R; Kochanowicz J; Kulakowska A; Kapica-Topczewska K
    Front Genet; 2023; 14():1107460. PubMed ID: 36816046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
    Nishigori C; Fujisawa H; Uyeno K; Kawaguchi T; Takebe H
    Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):146-50. PubMed ID: 1814424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in peripheral neuropathy in xeroderma pigmentosum complementation groups A and D as evaluated by nerve conduction studies.
    Lehky TJ; Sackstein P; Tamura D; Quezado M; Wu T; Khan SG; Patronas NJ; Wiggs E; Brewer CC; DiGiovanna JJ; Kraemer KH
    BMC Neurol; 2021 Oct; 21(1):393. PubMed ID: 34627174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebro-oculo-facio-skeletal syndrome with a nucleotide excision-repair defect and a mutated XPD gene, with prenatal diagnosis in a triplet pregnancy.
    Graham JM; Anyane-Yeboa K; Raams A; Appeldoorn E; Kleijer WJ; Garritsen VH; Busch D; Edersheim TG; Jaspers NG
    Am J Hum Genet; 2001 Aug; 69(2):291-300. PubMed ID: 11443545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide Excision Repair: From Molecular Defects to Neurological Abnormalities.
    Krasikova Y; Rechkunova N; Lavrik O
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
    Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
    Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological symptoms and natural course of xeroderma pigmentosum.
    Anttinen A; Koulu L; Nikoskelainen E; Portin R; Kurki T; Erkinjuntti M; Jaspers NG; Raams A; Green MH; Lehmann AR; Wing JF; Arlett CF; Marttila RJ
    Brain; 2008 Aug; 131(Pt 8):1979-89. PubMed ID: 18567921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Urinary Levels of 8-Hydroxy-2'-deoxyguanosine in a Japanese Child of Xeroderma Pigmentosum/Cockayne Syndrome Complex with Infantile Onset of Nephrotic Syndrome.
    Kondo D; Noguchi A; Tamura H; Tsuchida S; Takahashi I; Kubota H; Yano T; Oyama C; Sawaishi Y; Moriwaki S; Takahashi T
    Tohoku J Exp Med; 2016 Jul; 239(3):231-5. PubMed ID: 27396511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of point mutations in an ultraviolet-irradiated shuttle vector plasmid propagated in cells from Japanese xeroderma pigmentosum patients in complementation groups A and F.
    Yagi T; Tatsumi-Miyajima J; Sato M; Kraemer KH; Takebe H
    Cancer Res; 1991 Jun; 51(12):3177-82. PubMed ID: 2039995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.
    Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ
    Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding Xeroderma Pigmentosum Complementation Groups Using Gene Expression Profiling after UV-Light Exposure.
    Bowden NA; Beveridge NJ; Ashton KA; Baines KJ; Scott RJ
    Int J Mol Sci; 2015 Jul; 16(7):15985-96. PubMed ID: 26184184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare exon 10 deletion in POLH gene in a family with xeroderma pigmentosum variant correlating with protein expression by immunohistochemistry.
    Borroni RG; Diegoli M; Grasso M; Concardi M; Agozzino M; Vignini M; Arbustini E
    G Ital Dermatol Venereol; 2020 Jun; 155(3):349-354. PubMed ID: 32635709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.
    Bradford PT; Goldstein AM; Tamura D; Khan SG; Ueda T; Boyle J; Oh KS; Imoto K; Inui H; Moriwaki S; Emmert S; Pike KM; Raziuddin A; Plona TM; DiGiovanna JJ; Tucker MA; Kraemer KH
    J Med Genet; 2011 Mar; 48(3):168-76. PubMed ID: 21097776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.